Free Trial
NASDAQ:NXL

Nexalin Technology (NXL) Stock Price, News & Analysis

Nexalin Technology logo
$1.83 -0.02 (-1.08%)
Closing price 04/25/2025 04:00 PM Eastern
Extended Trading
$1.74 -0.10 (-5.19%)
As of 04/25/2025 07:40 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Nexalin Technology Stock (NASDAQ:NXL)

Key Stats

Today's Range
$1.77
$1.88
50-Day Range
$1.62
$3.30
52-Week Range
$0.53
$4.49
Volume
34,658 shs
Average Volume
1.24 million shs
Market Capitalization
$24.39 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$5.00
Consensus Rating
Buy

Company Overview

Nexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health in the United States and China. The company designs and develops Generation 2 and Generation 3, that is in clinical trials for the treatment of substance abuse issues related to opiate, cocaine, alcohol abuse, alzheimer's disease, and dementia. It also licenses and sells Nexalin Device, a non-invasive and undetectable to the human body that can provide relief to its afflicted with mental health issues. The company is based in Houston, Texas.

Nexalin Technology Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
49th Percentile Overall Score

NXL MarketRank™: 

Nexalin Technology scored higher than 49% of companies evaluated by MarketBeat, and ranked 140th out of 321 stocks in the business services sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Nexalin Technology has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Nexalin Technology has only been the subject of 1 research reports in the past 90 days.

  • Read more about Nexalin Technology's stock forecast and price target.
  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Nexalin Technology is -2.86, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Nexalin Technology is -2.86, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Nexalin Technology has a P/B Ratio of 4.26. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Nexalin Technology's valuation and earnings.
  • Percentage of Shares Shorted

    2.16% of the float of Nexalin Technology has been sold short.
  • Short Interest Ratio / Days to Cover

    Nexalin Technology has a short interest ratio ("days to cover") of 1.1, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Nexalin Technology has recently increased by 15.20%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Nexalin Technology does not currently pay a dividend.

  • Dividend Growth

    Nexalin Technology does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    2.16% of the float of Nexalin Technology has been sold short.
  • Short Interest Ratio / Days to Cover

    Nexalin Technology has a short interest ratio ("days to cover") of 1.1, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Nexalin Technology has recently increased by 15.20%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    Nexalin Technology has a news sentiment score of 0.54. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 1.01 average news sentiment score of Business Services companies.
  • News Coverage This Week

    MarketBeat has tracked 9 news articles for Nexalin Technology this week, compared to 1 article on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, Nexalin Technology insiders have bought more of their company's stock than they have sold. Specifically, they have bought $20,230.00 in company stock and sold $0.00 in company stock.

  • Percentage Held by Insiders

    24.00% of the stock of Nexalin Technology is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Only 0.65% of the stock of Nexalin Technology is held by institutions.

  • Read more about Nexalin Technology's insider trading history.
Receive NXL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Nexalin Technology and its competitors with MarketBeat's FREE daily newsletter.

NXL Stock News Headlines

Nexalin Technology receives IRB approval in Brazil, begins trial
Now I look stupid. Real stupid...
I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.
Nexalin completes five phases of virtual clinic, digital research system
See More Headlines

NXL Stock Analysis - Frequently Asked Questions

Nexalin Technology's stock was trading at $2.76 at the beginning of 2025. Since then, NXL stock has decreased by 33.7% and is now trading at $1.83.
View the best growth stocks for 2025 here
.

Nexalin Technology, Inc. (NASDAQ:NXL) released its quarterly earnings results on Friday, March, 14th. The company reported ($0.28) earnings per share for the quarter. The business earned $0.03 million during the quarter. Nexalin Technology had a negative trailing twelve-month return on equity of 187.59% and a negative net margin of 3,407.98%.

Nexalin Technology (NXL) raised $10 million in an initial public offering (IPO) on Friday, September 16th 2022. The company issued 2,315,000 shares at a price of $4.15 per share.

Shares of NXL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Nexalin Technology investors own include Meta Platforms (META), NVIDIA (NVDA), Faraday Future Intelligent Electric (FFIE), Intel (INTC), PayPal (PYPL), Advanced Micro Devices (AMD) and DoorDash (DASH).

Company Calendar

Last Earnings
3/14/2025
Today
4/26/2025
Next Earnings (Estimated)
5/09/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Electromedical equipment
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:NXL
Fax
N/A
Employees
3
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$5.00
High Stock Price Target
$5.00
Low Stock Price Target
$5.00
Potential Upside/Downside
+173.2%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-4,650,000.00
Net Margins
-3,407.98%
Pretax Margin
-3,418.41%

Debt

Sales & Book Value

Annual Sales
$168,721.00
Price / Cash Flow
N/A
Book Value
$0.43 per share
Price / Book
4.26

Miscellaneous

Free Float
10,111,000
Market Cap
$24.39 million
Optionable
Not Optionable
Beta
4.60
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report

This page (NASDAQ:NXL) was last updated on 4/26/2025 by MarketBeat.com Staff
From Our Partners